High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects 
Purpose of the study
To assess the association between CVR and PTH levels in HIV-infected patients (pts). PTH (r=0.148, p=0 .0134), creatinine (r=0.316, p<0.0001), triglycerides (r=0.300, p<0.0001) but not with vitamin D level (r= -0.102; p=0.123). After adjusting for PTH plasma levels, years of antiretroviral therapy (ART), years of HIV-infection, nadir and current CD4 cell count, detectable HIV-RNA, HIV transmission risk factor, triglycerides and creatinine levels, a CVR>10% was predicted by increasing PTH levels (OR=1.353 per 20-pg/mL increase, 95%CI: 1.074-1.802, p=0.028)as well as by increasing creatinine levels (OR=1.442 per 0.1-mg/dL increase, 95%CI:1.201-1.774, p=0.0002).
Methods
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Conclusions
Among HIV-infected patients elevated PTH levels were related to increased CVR and independently predicted a 10-years CVR above 10%. The interplay between bone metabolism and CVR needs to be further investigated. 
